What is the best medication for chronic lumbar pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Best Medication for Chronic Lumbar Pain

For chronic lumbar pain, NSAIDs are the first-line pharmacological option, with duloxetine (an SNRI) as the preferred second-line agent when NSAIDs are insufficient or contraindicated. 1

First-Line: NSAIDs

NSAIDs demonstrate small to moderate pain relief for chronic low back pain, though the benefits are smaller than previously thought 1. Among NSAIDs, COX-2 selective agents show the strongest evidence with a standardized mean difference of -12.03 for pain relief 2. The 2017 American College of Physicians systematic review—the highest quality guideline evidence available—establishes NSAIDs as the primary pharmacological option 1.

Key considerations for NSAIDs:

  • Use the lowest effective dose for the shortest duration
  • Monitor for gastrointestinal, cardiovascular, and renal adverse effects
  • Consider COX-2 selective agents to reduce GI risk in appropriate patients
  • Contraindicated in patients with cardiovascular disease, renal impairment, or active peptic ulcer disease

Second-Line: Duloxetine (SNRI)

Duloxetine is the only antidepressant with robust evidence for chronic low back pain 1. The ACP guideline specifically identifies duloxetine as effective with modest benefits (NNT = 10) 3. This makes it particularly valuable when NSAIDs fail or are contraindicated.

Duloxetine profile:

  • Number needed to treat: 10
  • Number needed to harm (discontinuation due to adverse events): 11
  • The benefit-to-harm ratio is nearly balanced, making patient selection important
  • Most effective for patients with neuropathic or nociplastic pain components

What NOT to Use

Avoid these medications based on guideline evidence:

  • Acetaminophen: Proven ineffective for both acute and chronic low back pain 1
  • Benzodiazepines: Ineffective for radiculopathy and chronic pain 1
  • Systemic corticosteroids: Not effective 1
  • Skeletal muscle relaxants: Only effective for acute pain with significant sedation; no role in chronic pain 1

Opioids: Use with Extreme Caution

Opioids show only modest short-term effects for chronic low back pain 1. The harm profile is concerning: NNT = 16 for benefit versus NNH = 5 for discontinuation due to adverse events 3. This unfavorable risk-benefit ratio, combined with addiction potential and the opioid crisis, makes opioids inappropriate for routine chronic low back pain management 4, 5.

If opioids are considered (rare circumstances only):

  • Reserve for severe pain unresponsive to all other treatments
  • Use lowest dose for shortest duration
  • Implement strict monitoring protocols
  • Consider partial opioid agonists (like buprenorphine) which show better safety profiles 2

Treatment Algorithm

  1. Start with NSAIDs (preferably COX-2 selective if no contraindications)

    • If inadequate response after 2-4 weeks → proceed to step 2
    • If contraindicated → proceed directly to step 2
  2. Add or switch to duloxetine (especially if neuropathic features present)

    • Start 30mg daily, increase to 60mg after 1 week
    • Assess response at 4-8 weeks
  3. If both fail, consider:

    • Gabapentinoids (insufficient evidence but may help if neuropathic component) 1
    • Tramadol (weak evidence, modest effects) 2
    • Referral to pain specialist for interventional approaches

Critical Pitfalls to Avoid

  • Do not prescribe acetaminophen—it wastes time and money with no benefit 1
  • Do not use muscle relaxants chronically—they cause sedation without functional improvement 1
  • Do not reflexively prescribe opioids—the harm-to-benefit ratio is unacceptable for chronic non-cancer pain 3, 4, 5
  • Do not continue ineffective medications—reassess at 4 weeks and discontinue if no meaningful improvement

Important Context

All effective medications provide only small to moderate, primarily short-term pain relief 1. Pain improvements are generally greater than functional improvements 1. Exercise is the only intervention with sustained benefit extending beyond the treatment period 3, making pharmacotherapy an adjunct to—not replacement for—physical rehabilitation and activity modification.

The goal of medication is to reduce pain enough to enable participation in physical therapy and maintain activity, not to eliminate pain completely 6, 7.

Related Questions

What are the treatment options for chronic back pain in a patient who is allergic to NSAIDs, muscle relaxants, gabapentin, and pregabalin (Lyrica)?
In a patient with chronic back pain currently taking gabapentin 600 mg twice daily, acetaminophen, and a lidocaine patch, would a short trial of cyclobenzaprine (Flexeril) 5 mg twice daily as needed for 7 days be appropriate for muscle spasm?
In a 77‑year‑old woman with extensive allergies to codeine, cyclobenzaprine (Flexeril), diphenhydramine, meperidine, methylprednisolone, morphine, promethazine, risperidone, sulfonamide antibiotics, and latex, who has uncontrolled chronic low‑back pain despite taking oxycodone‑acetaminophen (7.5 mg/325 mg) every 4–6 hours, acetaminophen 325 mg every 6 hours, and temazepam 15–30 mg at bedtime, what additional pharmacologic options are appropriate for pain management?
What is the appropriate management plan for back pain, including non‑pharmacologic measures, medication options, and indications for referral?
For a patient on citalopram 20 mg daily for one year with only modest benefit, who previously tried sertraline (Zoloft), duloxetine (Cymbalta) with good response but discontinued, and clonazepam (discontinued), currently uses tramadol 25 mg as needed for chronic back pain, occasional diphenhydramine (Unisom) for sleep, and recently stopped tirzepatide due to side effects, should I switch to duloxetine?
What are the indications for liver biopsy in a patient with chronic liver disease who has a suspected hepatic nodule?
What is the role of statins in primary prevention of ischemic stroke and myocardial infarction in adults without prior cardiovascular events?
Can oxybutynin be taken together with another medication for urinary urgency, such as another anticholinergic or the β‑3 agonist mirabegron?
What is the appropriate atenolol dosing regimen for a pediatric patient with a systemic hemangioma?
What is an appropriate life care plan for low back pain?
What is the target mean arterial pressure for adult patients with hepatorenal syndrome receiving norepinephrine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.